Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012
Income Statement [Abstract]
Sale of product	$ 1,680,696	$ 1,793,483	$ 5,153,534	$ 5,785,775
Cost of product	1,056,754	1,166,976	3,161,960	3,831,575
Gross profit	623,942	626,507	1,991,574	1,954,200
Operating costs and expenses:
Salaries and contract labor	404,082	477,335	1,272,319	1,406,626
General, administrative and consulting	435,734	494,587	1,372,284	1,471,704
Research and development	111,636	215,632	555,305	780,487
Total operating expenses	951,452	1,187,554	3,199,908	3,658,817
Nrt operating loss	(327,510)	(561,047)	(1,208,334)	(1,704,617)
Other income (expense):
Other income (expense)	11,083	22,729	(17,049)	47,811
Equity in net income of affiliate	5,044	13,943	36,677	45,925
Interest income	21	57	447	474
Interest expense	(119,839)	(80,266)	(329,291)	(111,493)
Total other income (expense)	(103,691)	(43,537)	(309,216)	(17,283)
Net loss	(431,201)	(604,584)	(1,517,550)	(1,721,900)
Loss attributable to non-controlling interest	7,094	13,058	25,341	24,995
Net loss attributable to International Isotopes Inc.	$ (424,107)	$ (591,526)	$ (1,492,209)	$ (1,696,905)
Net loss per common share - basic and diluted	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Weighted average common shares outstanding - basic and diluted	363,502,559	360,187,745	361,989,965	359,931,058